cetylpyridinium chloride anhydrous and Glycogen Storage Disease Type II

cetylpyridinium chloride anhydrous has been researched along with Glycogen Storage Disease Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, F; Katafuchi, T; Kroos, MA; Kumamoto, S; Nakamura, K; Oda, E; Okumiya, T; Okuyama, T; Reuser, AJ	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Glycogen Storage Disease Type II

Article	Year
High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population. Molecular genetics and metabolism, 2009, Volume: 97, Issue:3 Topics: alpha-Glucosidases; Asian People; Case-Control Studies; Glycogen Storage Disease Type II; Haplotypes; Health; Humans; Infant, Newborn; Japan; Neonatal Screening; Reproducibility of Results	2009

Article

Year

High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population.

Molecular genetics and metabolism, 2009, Volume: 97, Issue:3

Topics: alpha-Glucosidases; Asian People; Case-Control Studies; Glycogen Storage Disease Type II; Haplotypes; Health; Humans; Infant, Newborn; Japan; Neonatal Screening; Reproducibility of Results

2009